SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
+8.99%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$765M
AUM Growth
+$765M
(+22%)
Cap. Flow
+$104M
Cap. Flow
% of AUM
13.54%
Top 10 Holdings %
Top 10 Hldgs %
42.01%
Holding
140
New
30
Increased
44
Reduced
18
Closed
26
Top Buys
| 1 |
Johnson & Johnson
JNJ
|
$44.9M |
| 2 |
Bristol-Myers Squibb
BMY
|
$33.5M |
| 3 |
Viatris
VTRS
|
$17.2M |
| 4 |
argenx
ARGX
|
$10.3M |
| 5 |
PTC Therapeutics
PTCT
|
$9.87M |
Top Sells
| 1 |
SHPG
Shire pic
SHPG
|
$21.4M |
| 2 |
Amgen
AMGN
|
$18.5M |
| 3 |
Biogen
BIIB
|
$14.5M |
| 4 |
Pfizer
PFE
|
$14.1M |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
$13.6M |
Sector Composition
| 1 | Healthcare | 85.91% |
| 2 | Technology | 5.46% |
| 3 | Industrials | 2.69% |
| 4 | Financials | 1.45% |
| 5 | Materials | 0.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Delek US
DK
$1.67B
| – | – | -24,533 | Closed | -$1.23M |
|
127
Kornit Digital
KRNT
$669M
| – | – | -130,831 | Closed | -$2.33M |
|
128
Kura Oncology
KURA
$686M
| – | – | -351,953 | Closed | -$6.41M |
|
129
Lam Research
LRCX
$127B
| – | – | -14,597 | Closed | -$2.52M |
|
130
Meta Platforms (Facebook)
META
$1.86T
| – | – | -19,100 | Closed | -$3.71M |
|
131
Mohawk Industries
MHK
$8.24B
| – | – | -1,100 | Closed | -$236K |
|
132
Marvell Technology
MRVL
$54.2B
| – | – | -109,842 | Closed | -$2.36M |
|
133
Neurogene
NGNE
$264M
| – | – | -257,613 | Closed | -$683K |
|
134
Nice
NICE
$8.73B
| – | – | -60,043 | Closed | -$6.23M |
|
135
iShares S&P 100 ETF
OEF
$22B
| – | – | 0 | – | – |
|
|
136
Pfizer
PFE
$141B
| – | – | -390,000 | Closed | -$14.1M |
|
137
Rocket Pharmaceuticals
RCKT
$354M
| – | – | -34,475 | Closed | -$677K |
|
138
Radcom
RDCM
$212M
| – | – | -52,760 | Closed | -$1.04M |
|